Short answer
In the common version of ayahuasca, beta-carbolines from the vine Banisteriopsis caapi temporarily inhibit the MAO-A enzyme that normally breaks down DMT rapidly in the digestive system. This increases the oral bioavailability of DMT from another plant, allowing it to interact with several serotonin receptors, especially 5-HT2A. The real effect always also depends on the composition, the individual metabolism of the person and the context.
The term "mechanism of action" sometimes gives the impression of a complete explanation, when in fact it is a model with several levels of detail. At the molecular level, it describes enzymes and biological targets. On the systemic level - changes in heart rate, blood pressure, perception and attention. On the psychological level, there are people's reports about their experiences. Crossing between levels requires separate evidence: knowledge of a single target does not predict a particular thought, and subjective report does not establish a single molecular pathway.
Such a distinction protects against two mistakes. The first is to explain everything only by cultural expectations, ignoring pharmacology. The second is to assume that the name of the molecule fully explains the content of the experience. Current evidence supports the interaction of biological and contextual factors, but their relative weight for an individual cannot be calculated from a general description.
That is why a precise explanation always marks its own limits.
How the mechanism unfolds over time
After oral administration, the components do not appear in the blood at the same time. Dissolution, passage through the digestive system and absorption occur first. Beta-carbolines and DMT have their own concentration curves, and their metabolites are formed at different rates. Because of this, the onset of subjective changes cannot be tied to a single molecular switch.
Pharmacokinetics describes what the body does with a substance: absorption, distribution, metabolism, and excretion. Pharmacodynamics describes what a substance does to the body: binding to targets and subsequent physiological changes. In the case of ayahuasca, these two levels interact because one component changes the metabolism of the other.
The maximum plasma concentration and the most intense experience may not coincide from minute to minute. Molecular and network processes have their own dynamics, and subjective evaluation depends on attention and memory. Therefore, temporal data are better presented as ranges of observations in a particular study rather than as a universal schedule.
After the concentration is reduced, the acute pharmacological effect is weakened, but fatigue, emotional sensitivity or rumination may persist. This does not mean that the active substance continues to work at the same level. The aftermath may include physiological recovery, sleep, reassessment of memories, and responding to the context itself.
Metabolite studies help to test which pathways predominate, but do not provide a simple biomarker of what someone experiences. One concentration does not explain a specific image, thought or emotion. A scientifically valid model relates group trends to measurements and refrains from overly personal interpretation.
This temporal view also explains why data from different routes of administration cannot be mixed. They create different rates of increase and decrease in concentration. Even the same molecule under a different exposure profile can produce different dynamics, while the plant matrix adds even more variables.
Why DMT is usually broken down quickly
DMT is an endogenous tryptamine, which the body is able to metabolize quickly. When a substance is administered orally without other active ingredients, monoamine oxidase A in the intestine and liver converts a significant portion of it before it reaches the systemic circulation. This is called presystemic metabolism.
The phrase "DMT does not work orally" is a convenient shorthand, but too categorical. More precisely, bioavailability is very low under normal conditions due to rapid metabolism. The level of enzyme activity, amount of substance and other factors may differ, but the fundamental obstacle remains.
It is at this stage that the mechanism of ayahuasca differs from the action of isolated DMT by another route of entry. A common botanical combination contains substances that temporarily change the activity of the enzyme. The result is a different time profile, not just a "stronger version" of the same situation.
How beta-carbolines transiently alter MAO-A activity
The vine B. caapi contains harmine, harmaline and tetrahydroharmine. Harmine and harmaline act as reversible MAO-A inhibitors. Reversibility means that the interaction with the enzyme is not permanent: over time, the activity is restored. This distinguishes them from some older pharmacological inhibitors, but does not make the interaction insignificant.
When MAO-A is temporarily inhibited, some of the DMT avoids rapid breakdown, is absorbed, and enters the brain. At the same time, MAO-A is involved in the metabolism of other monoamines. Therefore, the mechanism is important not only for explaining psychoactivity, but also for understanding why the combination with other substances can change the physiological picture.
Tetrahydroharmine has a more complex profile, with studies debating its effects on the serotonin transporter and other targets. The contribution of each alkaloid is concentration-dependent, and concentrations in botanical samples are variable. Therefore, a correct explanation describes a group of interactions, rather than attributing the entire effect to a single component.
How DMT affects the serotonin system
Most often, the mechanism of psychedelic effects is associated with agonism of the serotonin target 5-HT2A. It is widespread in the cerebral cortex and is involved in the regulation of perception, attention and integration of signals. Its activation triggers intracellular processes and changes the functioning of neural networks.
DMT also interacts with other serotonin receptor subtypes and potential targets. The significance of some of these interactions in humans is still being determined. A list of interactions observed in the laboratory is not the same as a complete explanation of subjective experience: the molecular effect passes through complex networks of the brain, the current state of the body, and the sensory environment.
Current models of psychedelic action describe changes in network connectivity, predictive processing, and information processing flexibility. These are working scientific frameworks, not a definitive map of every image or emotion. They can explain common features, but do not predict the content of a particular person's experience.
Why the mechanism is not reduced to a single molecular target
Even if 5-HT2A is the key link, the herbal preparation contains several active alkaloids. They have different rates of absorption, metabolism and excretion. Concentrations change over time, so the subjective profile does not necessarily follow the curve of a single molecule.
The body is not a passive container either. Variations in enzymes, liver and kidney function, cardiovascular status, sleep, nutrition, and other substances can affect the reaction. Psychological context alters attention, interpretation, and memory, although it does not override pharmacology.
Finally, a description at the molecular level does not automatically answer the question of long-term consequences. A change in molecular signaling occurs within hours, whereas the meaning of an experience can take longer to form. The causal relationship between the acute mechanism and long-term changes requires separate studies.
How do laboratory formulations differ from a herbal decoction
A standardized formulation contains predetermined substances in a controlled ratio. This allows researchers to compare participants and more accurately relate concentration to changes over time. A botanical decoction has a complex matrix and natural variability, and additional plants can create new sources of uncertainty.
Studies of standardized DMT/harmine forms help test hypotheses about the mechanism. At the same time, they do not reproduce all the alkaloids, impurities and cultural context of the traditional preparation. PMID 39923404 refers specifically to the standardized formulation; its results should not be presented as a universal description of all ayahuasca.
Reverse transfer is also problematic: observing a non-standardized decoction does not give an accurate prediction for the pharmaceutical form. In each case, the conclusion must remain within the limits of the material, route of administration, and sample actually studied.
Four levels of correct explanation
The mechanism should be read as a sequence of interconnected levels: composition of a particular sample, absorption and metabolism, molecular interactions and changes in brain networks. No single level alone explains the content of the experience. It is helpful to first clarify the botanical and chemical composition, then match the model with the described effects and remember that even the common name can cover different materials.
- which active ingredients are actually measured;
- how their concentration changes over time;
- which molecular targets have been confirmed;
- where the author moves from data to hypothesis.
What is confirmed and what is being investigated
The best established sequence is that beta-carbolines inhibit MAO-A, the oral availability of DMT increases, and DMT activates serotonin molecular targets, particularly 5-HT2A. Pharmacokinetic studies detect alkaloids and their metabolites in biological samples and show different time profiles of the components.
Research continues to clarify the contribution of tetrahydroharmine, other molecular targets, neural networks and plasticity. Much of the mechanistic data comes from cellular, animal, or small human studies. Each level is useful, but none alone provides the full answer to a complex experience.
The greatest uncertainty occurs when the exact composition is unknown. Without analysis, exposure cannot be known, and without representative samples, the result cannot be generalized to everyone. A scientific explanation of a mechanism is a map of the underlying processes, not a guarantee of a predictable reaction.
How to read mechanistic statements
The statement "a substance binds to a molecular target" does not prove a clinical result. It is necessary to know the concentration, strength and nature of the interaction, as well as whether the corresponding effect has been observed in humans. Research on molecular targets answers the question "what might happen", but not always the question "what happens under real exposure".
Similarly, the increased activity of a brain area does not have a single psychological translation. A single signal can participate in multiple functions, and neuroimaging techniques have temporal and spatial limitations. A careful article explains how the study was conducted without treating a correlation as a way to read someone’s thoughts.
It is most reliable to compare evidence across several levels: known composition, pharmacokinetics, pharmacology of molecular targets, physiological measurements, and subjective reports. When they agree, the mechanistic model becomes more convincing. When data are lacking, an honest conclusion remains uncertain.